Author Correction: Virological assessment of hospitalized patients with COVID-2019 (Nature, (2020), 581, 7809, (465-469), 10.1038/s41586-020-2196-x);Virological assessment of hospitalized patients with COVID-2019

Nature

Volumn 581, Issue 7809, 2020, Pages 465-469

  Wölfel, Roman ^a   Corman, Victor M ^b   Guggemos, Wolfgang ^c   Seilmaier, Michael ^c   Zange, Sabine ^a   Müller, Marcel A ^b   Niemeyer, Daniela ^b   Jones, Terry C ^b,d   Vollmar, Patrick ^a   Rothe, Camilla ^e   Hoelscher, Michael ^e   Bleicker, Tobias ^b   Brünink, Sebastian ^b   Schneider, Julia ^b   Ehmann, Rosina ^a   Zwirglmaier, Katrin ^a   Drosten, Christian ^b   Wendtner, Clemens ^c  

^a BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c Klinikum Schwabing   (Germany)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA; ENVELOPE PROTEIN, SARS-COV-2; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN;

BLOOD; IMMUNITY; PATHOGENICITY; RESPIRATORY DISEASE; RNA; SEVERE ACUTE RESPIRATORY SYNDROME; URINE; VIRAL DISEASE; VIRUS;

ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORONAVIRUS DISEASE 2019; DIAGNOSTIC TEST; DISEASE COURSE; FECES ANALYSIS; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REPEAT PROCEDURE; RNA SEQUENCE; SARS CORONAVIRUS; SEROCONVERSION; THROAT CULTURE; UPPER RESPIRATORY TRACT; URINE SAMPLING; VIROLOGY; VIRUS IDENTIFICATION; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS SHEDDING; BETACORONAVIRUS; BLOOD; CHEMISTRY; CORONAVIRUS INFECTION; FECES; GENETICS; HOSPITALIZATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; LABORATORY TECHNIQUE; LUNG; NUCLEOTIDE SEQUENCE; PANDEMIC; PATHOGENICITY; PHARYNX; SINGLE NUCLEOTIDE POLYMORPHISM; SPUTUM; URINE; VIRUS PNEUMONIA;

CHINA;

CORONAVIRUS;

ANTIBODIES, VIRAL; BASE SEQUENCE; BETACORONAVIRUS; BLOOD; CLINICAL LABORATORY TECHNIQUES; CORONAVIRUS INFECTIONS; FECES; HOSPITALIZATION; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUNG; PANDEMICS; PHARYNX; PNEUMONIA, VIRAL; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, VIRAL; SEROCONVERSION; SPUTUM; URINE; VIRAL ENVELOPE PROTEINS; VIRAL LOAD; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 85083827704     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/s41586-020-2984-3     Document Type: Erratum

References (28)

1. Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727–733 (2020). DOI: 10.1056/NEJMoa2001017
2. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol. 5, 536–544 (2020).
3. WHO. Report of the WHO–China Joint Mission on Coronavirus Disease 2019 (COVID-19) https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (WHO, 2020).
4. Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181, 271–280 (2020).
5. Leung, G. M. et al. The epidemiology of severe acute respiratory syndrome in the 2003 Hong Kong epidemic: an analysis of all 1755 patients. Ann. Intern. Med. 141, 662–673 (2004). DOI: 10.7326/0003-4819-141-9-200411020-00006
6. Rothe, C. et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N. Engl. J. Med. 382, 970–971 (2020). DOI: 10.1056/NEJMc2001468
7. Holshue, M. L. et al. First case of 2019 novel coronavirus in the United States. N. Engl. J. Med. 382, 929–936 (2020). DOI: 10.1056/NEJMoa2001191
8. Hoehl, S. et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. N. Engl. J. Med. 382, 1278–1280 (2020). DOI: 10.1056/NEJMc2001899
9. Zou, L. et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 382, 1177–1179 (2020). DOI: 10.1056/NEJMc2001737
10. Young, B. E. et al. Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. J. Am. Med. Assoc. 323, 1488–1494 (2020). DOI: 10.1001/jama.2020.3204
11. Böhmer, M. et al. Outbreak of COVID-19 in Germany resulting from a single travel-associated primary case. Lancet Infect. Dis. https://doi.org/10.1016/S1473-3099(20)30314-5 (2020).
12. Corman, V. M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT–PCR. Euro Surveill. 25, 1–8 (2020).
13. Drosten, C. et al. Evaluation of advanced reverse transcription–PCR assays and an alternative PCR target region for detection of severe acute respiratory syndrome-associated coronavirus. J. Clin. Microbiol. 42, 2043–2047 (2004). DOI: 10.1128/JCM.42.5.2043-2047.2004
14. Peiris, J. S. et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet 361, 1767–1772 (2003). DOI: 10.1016/S0140-6736(03)13412-5
15. Poon, L. L. et al. Detection of SARS coronavirus in patients with severe acute respiratory syndrome by conventional and real-time quantitative reverse transcription-PCR assays. Clin. Chem. 50, 67–72 (2004). DOI: 10.1373/clinchem.2003.023663
16. Ksiazek, T. G. et al. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953–1966 (2003). DOI: 10.1056/NEJMoa030781
17. Drosten, C. et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1967–1976 (2003). DOI: 10.1056/NEJMoa030747
18. Peiris, J. S. et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 361, 1319–1325 (2003). DOI: 10.1016/S0140-6736(03)13077-2
19. Bertram, S. et al. Influenza and SARS-coronavirus activating proteases TMPRSS2 and HAT are expressed at multiple sites in human respiratory and gastrointestinal tracts. PLoS ONE 7, e35876 (2012). DOI: 10.1371/journal.pone.0035876
20. Xu, H. et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 12, 8 (2020). DOI: 10.1038/s41368-020-0074-x
21. Belouzard, S., Chu, V. C. & Whittaker, G. R. Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc. Natl Acad. Sci. USA 106, 5871–5876 (2009). DOI: 10.1073/pnas.0809524106
22. Corman, V. M. et al. Viral shedding and antibody response in 37 patients with Middle East respiratory syndrome coronavirus infection. Clin. Infect. Dis. 62, 477–483 (2016).
23. Zhou, J. et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci. Adv. 3, eaao4966 (2017). DOI: 10.1126/sciadv.aao4966
24. Leung, W. K. et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology 125, 1011–1017 (2003). DOI: 10.1016/j.gastro.2003.08.001
25. Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507–513 (2020). DOI: 10.1016/S0140-6736(20)30211-7
26. Drosten, C. et al. Transmission of MERS-coronavirus in household contacts. N. Engl. J. Med. 371, 828–835 (2014). DOI: 10.1056/NEJMoa1405858
27. Müller, M. A. et al. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect. Dis. 15, 559–564 (2015). DOI: 10.1016/S1473-3099(15)70090-3
28. Corman, V. M. et al. Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. Euro Surveill. 17, 20334 (2012).